MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/16/2026, 11:46 PM (Berlin time), refresh in progress.

Globus Medical Stock

Globus Medical, Inc.

GMEDNYSEMarkt
US$76.71
-2.7% today

Company data

Sector
Healthcare
Industry
Medical - Devices
Country
United States
CEO
Keith W. Pfeil
Employees
6,000
Market cap
$10.3 B
IPO
03/08/2012

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. The primary focus of the company is addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products, which…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Globus Medical stock: price history

16/10/25+31 %16/10/26

1D

-2.7%

1W

+2.8%

1M

+1.9%

6M

-19.5%

YTD

-12.1%

1Y

+31.0%

2Y

+2.4%

5Y

+0.4%

10Y

+234.0%

Next earnings date

Next earnings date

05/11/2026 (in 19 days)

Volatility around earnings

~108% stronger price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta

What does this mean?

Double bottom

Bullish

The price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Globus Medical stock scores

  • Valuation

    Visible after free registration

  • Trend

    Visible after free registration

  • Quality

    Visible after free registration

  • Dividend

    Visible after free registration

  • Growth

    Visible after free registration

  • Insider

    Visible after free registration

  • Earnings

    Visible after free registration

  • Revisions

    Visible after free registration

  • Sentiment

    Visible after free registration

  • Short Pressure

    Visible after free registration

Register for free

Unlock all 11 scores

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.

Ask the agents about Globus Medical

Analyst assessment of Globus Medical

PRICE TARGET LOW

US$80.00

CONSENSUS

US$95.13

MEDIAN

US$97.00

PRICE TARGET HIGH

US$117.00

0

STRONG BUY

26

BUY

9

HOLD

1

SELL

0

STRONG SELL

36

TOTAL · Buy

As of: 01/10/2026

ANALYST FIRMRATINGACTIONDATE
RBC CapitalOutperformmaintain01/10/2026
Wells FargoOverweightmaintain07/08/2026
Truist SecuritiesBuymaintain16/07/2026
RBC CapitalOutperformmaintain13/07/2026
StifelHoldmaintain08/07/2026
Piper SandlerOverweightmaintain15/06/2026
NeedhamBuymaintain08/05/2026
Wells FargoOverweightmaintain08/05/2026

Globus Medical stock metrics

P/E

19.32

P/B

2.18

EV/EBITDA

10.47

RETURN ON EQUITY

3.2%

NET MARGIN

19.2%

DEBT/EQUITY

0.02

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

99.3%

FLOAT SHARES

133,303,823

AVG. DAILY VOLUME (30D)

1,595,895

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

TOBIN JAMES R

DirectorOption exercise15,00053.75Spontaneous16/09/2026

TOBIN JAMES R

DirectorSale30,00074.58Spontaneous16/09/2026

TOBIN JAMES R

DirectorOption exercise15,00063.68Spontaneous16/09/2026

ZARRILLI STEPHEN T

DirectorOption exercise25,00053.27Spontaneous19/08/2026

ZARRILLI STEPHEN T

DirectorSale25,00087.04Spontaneous19/08/2026
Page 1 / 2

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: -2.7%

Forums (Reddit)

20/0921/0922/09

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Artemis Investment Management LLP541,840-31,58030/09/2026
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/451,403+26,52730/09/2026
CONGRESS ASSET MANAGEMENT CO /MA361,026+22,40130/09/2026
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC71,764+31,20130/09/2026
Oliver Luxxe Assets LLC45,088+2,51230/09/2026
Page 1 / 3

Smart Money

Register for free

Register now to see which funds are invested

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Comparable stocks

Frequently asked questions about Globus Medical stock

What does Globus Medical do?

Globus Medical, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.

The CEO is Keith W. Pfeil, the company employs around 6,000 people.

The IPO was on 03/08/2012; the stock trades on NYSE under the ticker GMED.

What do analysts say about Globus Medical stock?

36 analysts rate the stock, the consensus is Buy (as of 01/10/2026).

The average price target is US$95.13, ranging from US$80.00 to US$117.00, with a median of US$97.00.

This is an external assessment, not a statement by Market Jury.

When does Globus Medical report next?

The next earnings date is 05/11/2026.

Around past earnings, price swings were roughly 108% stronger than usual.

Does Globus Medical pay a dividend?

No, Globus Medical currently does not pay a dividend.

Which stocks are comparable to Globus Medical?

Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.

How can I get Globus Medical stock analyzed?

Clicking "Analyze stock" lets five strategies assess Globus Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.